Unique ID issued by UMIN | UMIN000002933 |
---|---|
Receipt number | R000003568 |
Scientific Title | A multi-centre trial for the treatment of oral leukoplakia with the aid of chemopreventive agents |
Date of disclosure of the study information | 2009/12/23 |
Last modified on | 2009/12/23 16:00:16 |
A multi-centre trial for the treatment of oral leukoplakia with the aid of chemopreventive agents
Chemoprevention of oral leukoplakia
A multi-centre trial for the treatment of oral leukoplakia with the aid of chemopreventive agents
Chemoprevention of oral leukoplakia
Japan |
Oral leukoplakia
Oral surgery | Dental medicine |
Malignancy
NO
To evaluate the utility of low-dose beta-carotene with vitamin C supplements for the treatment and against malignant transformation of oral leukoplakia among non-smokers
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Clinical remission
Likelihood of malignant transformation
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
YES
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Food |
One year supplement of 5mg 2 times/day of beta-carotene and 250mg 2 times/day of vitamin C
One year supplement of 25mg 2 times/day of vitamin C
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1) Predominantly white lesion of oral mucosa clinically diagnosed as leukoplakia based on the WHO criteria and confirmed histologically
2) Both non-dysplastic and those with mild to moderate dysplasia histo-pathologically
3) Non-smokers or ex-smokers more than 3 months
4) Discontinuing to take any over the counter micronutrient supplements 4 weeks prior to entering the trial
1) Any other specific disorders that could appear as a white lesion such as frictional keratosis, hairly leukoplakia, leukoedema, oral lichen planus and erythroplakia
2) Severe dysplasia, carcinoma in situ or micro-invasive carcinoma
3) Current smokers
4) Having adverse medical problems
5) Pregnancy
46
1st name | |
Middle name | |
Last name | Toru Nagao |
Aichi-Gakuin University School of Dentistry
Department of Maxillofacial Surgery
2-11,Suemori-dori,Chikusa-ku, Nagoya 464-8651,Japan
052-759-2160
1st name | |
Middle name | |
Last name | Hideo Fukano |
Chemoprevention Study Group for Oral Leukoplakia
Department of Maxillofacial Surgery, Aichi-Gakuin University School of Dentistry
2-11,Suemori-dori,Chikusa-ku, Nagoya 464-8651,Japan
052-759-2160
hifu0125@dpc.aichi-gakuin.ac.jp
Department of Maxillofacial Surgery, Aichi-Gakuin University School of Dentistry
Great Britain Sasakawa Foundation, UK
Outside Japan
UK
Department of Oral Medicine, WHO Collaborating Centre for Oral Cancer Precancer,King's College Dental Institute at Guy's,King's&St.Thomas' Hospitals London,UK
DSM Nutrition Japan
NO
愛知学院大学歯学部附属病院(愛知県)
2009 | Year | 12 | Month | 23 | Day |
Published
The overall clinical response rate in the experimental arm (low dose of beta-carotene and vitamin C) was 17.4% and 4.3% in the placebo arm (P=0.346). During the follow-up period (median 60 months), two subjects in the experimental arm and three subjects in the control arm developed oral cancer. The relative risk for supplementing with beta-carotene and vitamin C was 0.77 (95%CI: 0.28-1.89) (P=0.580) by the Cox proportional hazards model. No untoward side effects have been noted.
The supplemental low dose of beta-carotene and vitamin C for oral leukoplakia among non-smokers were neither effective for clinical remission nor for protection against cancer development statistically.
(The Annual Conference of the British Association of Oral Surgeons ,December 2009, Birmingham,UK)
Completed
2000 | Year | 12 | Month | 22 | Day |
2001 | Year | 06 | Month | 01 | Day |
2009 | Year | 10 | Month | 01 | Day |
2009 | Year | 11 | Month | 01 | Day |
2009 | Year | 11 | Month | 01 | Day |
2009 | Year | 11 | Month | 01 | Day |
2009 | Year | 12 | Month | 23 | Day |
2009 | Year | 12 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003568